These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6641543)
1. [Natural killer cells and tumor resistance]. Saksela E Duodecim; 1983; 99(16):1032-8. PubMed ID: 6641543 [No Abstract] [Full Text] [Related]
2. Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth. Herberman RB Concepts Immunopathol; 1985; 1():96-132. PubMed ID: 3916408 [No Abstract] [Full Text] [Related]
3. Natural killer cells and their possible roles in host resistance against tumors. Herberman RB Transplant Proc; 1984 Apr; 16(2):476-8. PubMed ID: 6719548 [No Abstract] [Full Text] [Related]
4. Natural killer cells in innate immunity and cancer. Becknell B; Caligiuri MA J Immunother; 2008 Oct; 31(8):685-92. PubMed ID: 18779751 [No Abstract] [Full Text] [Related]
5. [Natural killer cells in the interferon therapy of cancer patients]. Shparyk IaV; Bilynskiĭ BT; Shloma DV Vopr Onkol; 1991; 37(2):136-43. PubMed ID: 1707569 [No Abstract] [Full Text] [Related]
6. Principles of tumor immunology. Den Otter W Postepy Hig Med Dosw; 1988; 42(2):117-24. PubMed ID: 3075997 [No Abstract] [Full Text] [Related]
7. [Natural killers during the treatment of patients with solid tumors]. Bilynskiĭ BT; Shparik IaV Vopr Onkol; 1990; 36(2):131-8. PubMed ID: 2180206 [No Abstract] [Full Text] [Related]
8. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Trinchieri G Semin Immunol; 1995 Apr; 7(2):83-8. PubMed ID: 7579198 [TBL] [Abstract][Full Text] [Related]
9. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies. Fujii S Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215 [TBL] [Abstract][Full Text] [Related]
11. The role of natural killer cells in innate resistance to infection. Hunter CA J Immunol; 1997 Oct; 159(8):4127. PubMed ID: 9379004 [No Abstract] [Full Text] [Related]
15. Analyses and perspectives in cancer immunotherapy. Nguyen van Binh P; Duc HT Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826 [TBL] [Abstract][Full Text] [Related]
16. NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance. Chang CC; Ferrone S Semin Cancer Biol; 2006 Oct; 16(5):383-92. PubMed ID: 16931041 [TBL] [Abstract][Full Text] [Related]
17. The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients. Schendel DJ; Falk CS; Frankenberger B; Noessner E; Schleypen J; Pohla H Urologe A; 2004 Sep; 43 Suppl 3():S133-5. PubMed ID: 15179552 [No Abstract] [Full Text] [Related]